Moderna, Inc. (ETR:0QF)
23.24
+0.46 (2.04%)
At close: Jun 27, 2025, 5:30 PM CET
Moderna Revenue
Moderna had revenue of $108.00M USD in the quarter ending March 31, 2025, a decrease of -35.33%. This brings the company's revenue in the last twelve months to $3.18B, down -38.35% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.18B
Revenue Growth
-38.35%
P/S Ratio
2.90
Revenue / Employee
$547.76K
Employees
5,800
Market Cap
8.53B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Moderna News
- 1 day ago - US stocks threatens to close at record levels but closes just off record levels - Forexlive
- 9 days ago - Major US stocks close mixed. Dow is lower. S&P near unchanged. NASDAQ marginally higher - Forexlive
- 9 days ago - Moderna's Options: A Look at What the Big Money is Thinking - Benzinga
- 10 days ago - AI Meets Oncology: Caris Life Sciences' $5.35B IPO Tests Investor Appetite for Precision Medicine - Benzinga
- 11 days ago - Moderna, Inc. (MRNA) Presents at Barclays Speaking the Science Call Series Transcript - Seeking Alpha
- 13 days ago - US experts fear all vaccines at risk as Trump officials target mRNA jabs - The Guardian
- 14 days ago - FDA approves expanded use of Moderna's RSV shot, but uncertainty remains - The Hill
- 14 days ago - FDA approves expanded use of Modernas RSV shot, but uncertainty remains - Yahoo